Share these talks and lectures with your colleagues
Invite colleaguesThe impact of the COVID-19 pandemic on medical and travel insurance pricing and fraud risks: An exploratory study
Abstract
This study investigates how the emergence of the coronavirus disease-2019 (COVID-19) pandemic has raised many concerns in medical and travel insurance, how insurers perceive and react to this pandemic, and the role of governments in this new context, with a particular focus on the Gulf Cooperation Council region (GCC). Data has been collected using archival research and conversations with some chief risk officers (CROs), internal auditors and insurance practitioners. The authors explain how, following the COVID-19 pandemic, the GCC medical and travel insurance industry faces pricing and fraud risks that need specific planning and control. In the GCC, pricing risk is found to represent an immediate risk that is not easy to manage as historical data is not available. This causes the failure of the present risk models in anticipating the probability and severity of the claims. As a response, insurers rely on scenario analysis and brainstorming to anticipate the costs. Fraud risk is harder to manage, as traditional internal controls are inefficient. Further, both risk managers and internal auditors are currently struggling because of the ‘working from home’ situation and the massive digital transformation in all the transactions. Moreover, the time spent in fraud investigation will delay the payment for hospitalised insurance claims, which would raise concerns about the insurer’s reputation. To resolve this conundrum and manage reputational risk, most GCC insurers seek trade-offs and negotiations with the insured. The authors’ observations and analyses revealed that current responses by GCC insurers are insufficient and need enhancements. Therefore, the authors propose some potential policy solutions that would help insurers overcome both pricing and fraud risks. Through explaining medical and travel insurance risks and proposing potential solutions in this emerging market, this paper provides some practical insights for insurance researchers, insurers and CROs who are seeking solutions to pandemic-related risks.
The full article is available to subscribers to the journal.
Author's Biography
Hala Naseeb is an insurance practitioner with ten years of experience especially in the life insurance field. She is currently a trainer at the Bahrain Institute of Banking and Finance. Hala holds an Advanced Diploma in Insurance qualification from the Chartered Insurance Institute in the United Kingdom and an Associate at Life Management Institute qualification from the Life Management Office Association in the USA. She is also a graduate from the London School of Economics.
Ahmed A. Diab is an assistant professor at Prince Sultan University Saudi Arabia and a lecturer at Beni-Suef University, Egypt. Ahmed holds a PhD in accountancy from the University of Aberdeen, United Kingdom.
Abdelmoneim Metwally is a risk-based control professional specialist in the Middle East and North African region. Abdelmoneim worked during his early career as an internal auditor. Currently, he is a lecturer in Accounting, Banking and Finance at Bangor University, BIBF Campus, Bahrain, and a lecturer in Accounting, Faculty of Commerce, Assiut University, Egypt. He holds a PhD in Accounting and Finance from the University of Glasgow and is a fellow in the Higher Education Academy, United Kingdom.
Citation
Naseeb, Hala, Diab, Ahmed A. and Metwally, Abdelmoneim (2020, December 1). The impact of the COVID-19 pandemic on medical and travel insurance pricing and fraud risks: An exploratory study. In the Journal of Risk Management in Financial Institutions, Volume 14, Issue 1. https://doi.org/10.69554/CGSD7961.Publications LLP